Welcome to LookChem.com Sign In|Join Free
  • or
BMS 791325 is a non-nucleoside, nonstructural protein 5B (NS5B) polymerase inhibitor used for the treatment of hepatitis C virus (HCV). It is a part of a fixed-dose combination product and was discovered and developed by Bristol-Myers Squibb.

958002-33-0

Post Buying Request

958002-33-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

958002-33-0 Usage

Uses

Used in Pharmaceutical Industry:
BMS 791325 is used as an antiviral drug for the treatment of hepatitis C virus (HCV). It works by binding to the allosteric, noncatalytic "Thumb 1" site of NS5B, resulting in a decreased rate of viral RNA synthesis and replication. It is combined with other antiviral drugs such as asunaprevir and daclatasvir to enhance the treatment efficacy and overcome drug resistance.

Synthesis

The syntheses of asunaprevir and declatasvir were described in an earlier review article.Condensation of indole-6-carboxylic acid (1) with cyclohexanone under basic conditions gave acid 2 in quantitative yield. Hydrogenation of the double bond in 2 using Pearlman’s catalyst was followed by esterification to give ester 3 in high yield. Bromination of the indole at the 2-position was accomplished with pyridinium tribromide, and this was followed by saponification to provide acid 4. Treatment of 4 with carbonyldiimidazole (CDI) followed by N,N- dimethylsulfamide and 1, 8 - diazabicyclo[5.4.0]undec-7-ene (DBU) gave compound 5 in 74% yield. Suzuki coupling of 5 with commercial boronic acid 6 provided intermediate 7, which converted to hemiaminal 8 upon continued heating in 61% yield. Compound 8 was then treated with methyl 2-(dimethoxyphosphoryl)acrylate (9) to affect a tandem conjugate addition and Horner?Wadsworth? Emmons (HWE) olefination to give ester 10. Alternatively, the Suzuki coupling reaction of 5 with 6 could be stopped at intermediate 7, which could be treated with 9 to promote the tandem conjugate addition/HWE to give 10. Corey?-Chaykovsky cyclopropanation of 10 using sodium hydride and trimethylsulfoxonium iodide followed by chiral separation provided cyclopropane 11 in good yield and >99% enantiomeric excess (ee). Saponification of the methyl ester of 11 followed by coupling with 3-methyl-3,8-diazabicyclo[3.2.1]- octane dihydrochloride (12) gave beclabuvir (I) in high yield.

Check Digit Verification of cas no

The CAS Registry Mumber 958002-33-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,8,0,0 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 958002-33:
(8*9)+(7*5)+(6*8)+(5*0)+(4*0)+(3*2)+(2*3)+(1*3)=170
170 % 10 = 0
So 958002-33-0 is a valid CAS Registry Number.

958002-33-0Downstream Products

958002-33-0Relevant academic research and scientific papers

Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors

-

Page/Page column 54-55, (2008/06/13)

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 958002-33-0